Company Performance Metrics
Susan Linke: CFO- Kjell Thörnbring: CEO and President
Artimplant AB, a medical technology company, engages in the development, production, and marketing of degradable implants that regenerate body functions following disease and injury to locomotor organ tissue. The company produces implants for the treatment of osteoarthritis and the reinforcement of weakened soft tissue. It offers CMC Spacer for the
treatment of thumb base joint osteoarthritis; STT Spacer for the treatment of osteoarthritis in STT joint in the wrist; MTP Spacer for osteoarthritis in the big toe joint; and CMC Arthro for the treatment of osteoarthritis in the thumb base joint. The company also provides Tissue Reinforcement, ATR, which is a mesh used as reinforcement in conjunction with the repair of soft tissues, including tendons, ligaments, and joint capsule; and Cosmetic, a product for soft tissue augmentation in the mouth. It sells its products through agents and distributors under the Artimplant brand, as well as through licensees in the United States and Europe. Artimplant AB was founded in 1990 and is headquartered in Vastra Frolunda, Sweden.
